← FDA Drug Approvals (Drugs@FDA)

MIMRYLO

NDA · New Drug Application · Sponsor: TAKEDA PHARMS AM · Approved 2026-08-28

Drug application

FDA Application #

NDA220605

Application type

New Drug Application

Brand name

MIMRYLO

Generic name

RUSFERTIDE

Active ingredients

RUSFERTIDE ACETATE

Dosage form

POWDER

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

TAKEDA PHARMS AM

Manufacturer

Takeda Pharmaceuticals America, Inc.

First approval

2026-08-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown